By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $213.93
Target stock price (averages with growth) $227.74
Target stock price (averages with no growth) $103.56
Target stock price (manual assumptions) $214.14

 

The following company description is from Google Finance: http://www.google.com/finance?q=alxn

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company’s products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company’s clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Alexion Pharmaceuticals, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Alexion Pharmaceuticals, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $138.33
  • Growth: 0.2
  • Current EPS (TTM): $2.31
  • P/E: 60
  • Future EPS Calc: $5.74
  • Future Stock Price Calc: $344.88
  • Target stock price: $214.14

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Align Technology, Inc.
Stock ticker ALGN
Live stock price [stckqut]ALGN[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $268.51
Target stock price (averages with growth) $296.76
Target stock price (averages with no growth) $134.74
Target stock price (manual assumptions) $269.77

The following company description is from Google Finance: http://www.google.com/finance?q=algn
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Align Technology, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Align Technology, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $174.05
  • Growth: 0.2
  • Current EPS (TTM): $2.91
  • P/E: 60
  • Future EPS Calc: $7.24
  • Future Stock Price Calc: $434.46
  • Target stock price: $269.76

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name ABIOMED, Inc.
Stock ticker ABMD
Live stock price [stckqut]ABMD[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $237.
Target stock price (averages with growth) $262.38
Target stock price (averages with no growth) $119.66
Target stock price (manual assumptions) $47.28

 

The following company description is from Google Finance: http://www.google.com/finance?q=abmd

ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company’s product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company’s products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in ABIOMED, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of ABIOMED, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $152.98
  • Growth: 0.2
  • Current EPS (TTM): $1.7
  • P/E: 18
  • Future EPS Calc: $4.23
  • Future Stock Price Calc: $76.14
  • Target stock price: $47.27

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Apple Inc.
Stock ticker AAPL
Live stock price [stckqut]AAPL[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Fair
EPS growth Fair
P/E growth Fair
EBIT growth Fair

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $191.14
Target stock price (averages with growth) $177.56
Target stock price (averages with no growth) $89.8
Target stock price (manual assumptions) $181.

The following company description is from Google Finance: http://www.google.com/finance?q=aapl

Apple Inc. (Apple) designs, manufactures and markets mobile communication and media devices, personal computers, and portable digital music players, and a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications. The Company’s products and services include iPhone, iPad, Mac, iPod, Apple TV, a portfolio of consumer and professional software applications, the iOS and OS X operating systems, iCloud, and a variety of accessory, service and support offerings. The Company also delivers digital content and applications through the iTunes Store, App StoreSM, iBookstoreSM, and Mac App Store. The Company distributes its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers, and value-added resellers. In February 2012, the Company acquired app-search engine Chomp.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Apple Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Apple Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $157.11
  • Growth: 0.13
  • Current EPS (TTM): $8.79
  • P/E: 18
  • Future EPS Calc: $16.19
  • Future Stock Price Calc: $291.51
  • Target stock price: $181

[/s2If]
I hope that this makes you a Confident Investor.

By:
On:
In: Content for book owners, Daily Indicators
With: 0 Comments
Stock ticker Stock name Last Close Recommendation
AAPL Apple Inc. $156.3900 Strong Buy or Hold, but there are some concerns
ABMD ABIOMED, Inc. $151.0100 Strong Buy or Hold
ALGN Align Technology, Inc. $169.3000 Strong Buy or Hold
ALXN Alexion Pharmaceuticals, Inc. $136.6400 Strong Buy or Hold
AMAT Applied Materials, Inc. $42.8200 Concerned, but watch close as good things may happen soon
AMZN Amazon.com, Inc. $987.5800 Concerned, but watch close as good things may happen soon
AYI Acuity Brands, Inc. $199.8700 Very Concerned, may need to wait
AZPN Aspen Technology, Inc. $57.7900 Strong Buy or Hold
BABA Alibaba Group Holding Ltd $153.3300 Very Concerned, may need to wait
BWLD Buffalo Wild Wings $112.5500 Very Concerned, may need to wait
CBPO China Biologic Products Inc $97.0400 Very Concerned, may need to wait
COF Capital One Financial Corp. $84.4100 Concerned, but watch close as good things may happen soon
CRUS Cirrus Logic, Inc. $57.4500 Very Concerned, may need to wait
CVCO Cavco Industries, Inc. $136.5000 Concerned, but watch close as good things may happen soon
DPZ Domino’s Pizza, Inc. $196.7900 Very Concerned, may need to wait
EW Edwards Lifesciences Corp $116.1900 Very Concerned, may need to wait
EXR Extra Space Storage, Inc. $77.7500 Concerned, but watch close as good things may happen soon
FB Facebook Inc $169.6200 Strong Buy or Hold, but there are some concerns
GOOGL Alphabet Inc $945.7900 Very Concerned, may need to wait
GTN Gray Television, Inc. $13.5000 Concerned, but watch close as good things may happen soon
GWR Genesee & Wyoming Inc $66.9500 Very Concerned, may need to wait
HDSN Hudson Technologies, Inc. $7.9300 Very Concerned, may need to wait
HOG Harley-Davidson Inc $48.3400 Very Concerned, may need to wait
HSKA Heska Corp $98.7500 Concerned, but watch close as good things may happen soon
HZO MarineMax Inc $15.5500 Very Concerned, may need to wait
IDXX IDEXX Laboratories, Inc. $152.6000 Concerned, but watch close as good things may happen soon
LNCE Snyder’s-Lance Inc $34.6600 Concerned, but watch close as good things may happen soon
LULU Lululemon Athletica inc. $61.7600 Concerned, but watch close as good things may happen soon
MCK McKesson Corporation $154.6900 Very Concerned, may need to wait
MEI Methode Electronics Inc. $38.9500 Very Concerned, may need to wait
MET Metlife Inc $53.9200 Very Concerned, may need to wait
MIDD Middleby Corp $128.3500 Concerned, but watch close as good things may happen soon
MNST Monster Beverage Corporation $52.7100 Concerned, but watch close as good things may happen soon
MRK Merck & Co., Inc. $63.1000 Very Concerned, may need to wait
NFLX Netflix, Inc. $180.2700 Concerned, but watch close as good things may happen soon
NVDA NVIDIA Corporation $167.2100 Concerned, but watch close as good things may happen soon
PCLN Priceline Group Inc $2032.7700 Strong Buy or Hold, but there are some concerns
REGN Regeneron Pharmaceuticals Inc $468.7600 Concerned, but watch close as good things may happen soon
SAM Boston Beer Company Inc $148.4500 Possible Buy or Hold, but some concerns
SBUX Starbucks Corporation $55.4400 Very Concerned, may need to wait
STZ Constellation Brands, Inc. $193.8200 Very Concerned, may need to wait
SUI Sun Communities Inc $88.4300 Concerned, but watch close as good things may happen soon
SWKS Skyworks Solutions Inc $102.5500 Concerned, but watch close as good things may happen soon
THRM Gentherm Inc $31.5000 Very Concerned, may need to wait
TMO Thermo Fisher Scientific Inc. $176.3300 Very Concerned, may need to wait
TRN Trinity Industries Inc $28.2200 Very Concerned, may need to wait
UA Under Armour Inc $16.6100 Very Concerned, may need to wait
ULTA Ulta Beauty Inc $250.2000 Very Concerned, may need to wait